Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 11/20 | 0.46 |
| ▸ | CNR1 | P21554 | 8/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HRH2 | P25021 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL838460 | 0.97 | MAPT (0.50) | MAPTCNR2CNR1SMN1; SMN2HRH2 | |
| SCHEMBL16746639 | 0.95 | MAPT (0.48) | MAPTCNR2CNR1SMN1; SMN2HRH2 | |
| SCHEMBL838090 | 0.95 | MAPT (0.55) | MAPTCNR2CNR1SMN1; SMN2HRH2 | |
| SCHEMBL13427328 | 0.94 | MAPT (0.47) | MAPTCNR2CNR1SMN1; SMN2HRH2 | |
| SCHEMBL13182760 | 0.94 | MAPT (0.47) | MAPTCNR2CNR1SMN1; SMN2HRH2 | |
| SCHEMBL14369603 | 0.93 | MAPT (0.42) | MAPTCNR2CNR1SMN1; SMN2HRH2 | |
| SCHEMBL838132 | 0.92 | MAPT (0.46) | MAPTCNR2CNR1SMN1; SMN2HRH2 | |
| SCHEMBL13135373 | 0.92 | MAPT (0.46) | MAPTCNR2CNR1SMN1; SMN2HRH2 | |
| SCHEMBL13583857 | 0.91 | MAPT (0.47) | MAPTCNR2CNR1SMN1; SMN2HRH2 | |
| SCHEMBL13584035 | 0.91 | MAPT (0.47) | MAPTCNR2CNR1SMN1; SMN2HRH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9005484-B2 | Low polarity nano silver gels | XEROX CORPORATION (US) | 2015-04-14 | — | — | US | disclosed |
| US-8916084-B2 | Ultra-violet curable gellant inks for three-dimensional printing and digital fabrication applications | XEROX CORPORATION (US) | 2014-12-23 | — | — | US | disclosed |
| US-8791202-B2 | Phase change ink compositions | XEROX CORPORATION (US) | 2014-07-29 | — | — | US | disclosed |
| US-8758865-B2 | Ultra-violet curable gellant inks for tactile and regular print applications for signature and document authentication | XEROX CORPORATION (US) | 2014-06-24 | — | — | US | disclosed |
| US-8702223-B2 | Infrared-absorbing radiation-curable inks | XEROX CORPORATION (US) | 2014-04-22 | — | — | US | disclosed |
| US-8651849-B2 | Digitally prepared stamp masters and methods of making the same | XEROX CORPORATION (US) | 2014-02-18 | — | — | US | disclosed |
| US-8545002-B2 | Ink set and manufacturing process for phase change inks | XEROX CORPORATION (US) | 2013-10-01 | — | — | US | disclosed |
| US-20120236065-A1 | Magnetic Curable Inks | XEROX CORPORATION (US) | 2012-09-20 | — | — | US | disclosed |
| US-20120190765-A1 | ROBUST CURABLE SOLID INKS | XEROX CORPORATION (US) | 2012-07-26 | — | — | US | disclosed |
| US-20120175820-A1 | DIGITALLY PREPARED STAMP MASTERS AND METHODS OF MAKING THE SAME | XEROX CORPORATION (US) | 2012-07-12 | — | — | US | disclosed |
| US-20100247783-A1 | LOW POLARITY NANO SILVER GELS | XEROX CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100124611-A1 | Phase Change Inks Containing Graphene-Based Carbon Allotrope Colorants | XEROX CORPORATION (US) | 2010-05-20 | — | — | US | disclosed |
| US-7699922-B2 | Organic phase change carriers containing nanoparticles, phase change inks including same and methods for making same | XEROX CORPORATION (US) | 2010-04-20 | — | — | US | disclosed |
| US-20100055415-A1 | Ultra-Violet Curable Gellant Inks For Tactile And Regular Print Applications For Signature And Document Authentication | XEROX CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| US-20100055407-A1 | Ultra-Violet Curable Gellant Inks For Creating Tactile Text And Images For Packaging Applications | XEROX CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| US-20100055423-A1 | Machine Readable Code Comprising Ultra-Violet Curable Gellant Inks | XEROX CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| US-20100055484-A1 | Ultra-Violet Curable Gellant Inks For Three-Dimensional Printing And Digital Fabrication Applications | XEROX CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| US-20090082489-A1 | Phase change ink compositions | XEROX CORPORATION | 2009-03-26 | — | — | US | disclosed |
| US-20080090928-A1 | Ink set; radiation curable fluorescent ink with a curable monomer or oligomer, photoinitiator, and a fluorescent material, which fluoresces to cause a visible change in the appearance of the ink | XEROX CORPORATION (US) | 2008-04-17 | — | — | US | disclosed |
| US-20070283846-A1 | Organic Phase Change Carriers Containing Nanoparticles, Phase Change Inks Including Same and Methods for Making Same | XEROX CORPORATION (US) | 2007-12-13 | — | — | US | disclosed |